Skip to main content
SRTA logo

Strata Critical Medical, Inc.

SRTANASDAQHealthcareMedical Care Facilities

$4.53Today:- (-)1Y −13.03%

As of Oct 16, 2026 close

Market cap
$374.17M
P/E (TTM)
9.30
Forward P/E
-
Dividend yield
-
52-week range
$3.95$6.50
Volume (live)
-
Avg. volume (3M)
837.99K

Strata Critical Medical (SRTA) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Strata Critical Medical used $48.91M of cash in operating activities and spent $11.01M on capital expenditures. That left free cash flow of −$59.92M. It repurchased $9.11M of its own shares.

Strata Critical Medical Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Strata Critical Medical, Inc. (SRTA) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Sep 2021Sep 2020Sep 2019
Operating Activities
Net Income41.35-27.31-56.08-27.26-36.92-40.05-10.16-10.84
Depreciation & Amortization8.195.967.115.731.170.600.530.47
Deferred Income Tax0.43-0.26-1.47-0.77--3.640.000.00
Stock Based Compensation17.8319.8912.508.2811.289.620.490.32
Change in Working Capital-9.08-3.01-6.74-0.02-2.20-2.20-1.67-0.28
Change in Accounts Receivable-12.03-1.00-10.25-5.35-1.74-0.41-0.59-0.17
Change in Accounts Payable2.380.000.009.902.521.960.000.00
Change in Other Working Capital-52.43-2.013.52-5.31-4.90-3.75-1.08-0.12
Other Operating Activities-52.432.2012.32-23.865.4020.060.000.03
Net Cash from Operating Activities-48.91-2.52-32.35-37.13-21.63-15.62-10.82-10.30
Investing Activities
Capital Expenditures-11.01-32.99-2.11-0.73-0.49-0.30-0.38-0.85
Acquisitions-69.35-2.23-0.04-48.10-23.07-23.070.00-0.20
Purchases of Investments-146.26-143.26-265.97-228.02-308.77-308.770.000.00
Sales/Maturities of Investments296.36177.45285.07356.3828.5111.300.000.00
Other Investing Activities-1.42-2.110.14-0.19--0.500.00-0.25
Net Cash from Investing Activities69.75-1.0217.0979.34-316.17-321.34-0.38-1.05
Financing Activities
Debt Repayment0.000.000.000.00-1.17-1.171.170.00
Common Stock Issued0.190.000.000.09335.040.140.000.00
Common Stock Repurchased-9.11-0.240.00-1.17-3.170.000.000.00
Other Financing Activities-9.11-5.52-0.08-1.17-333.280.020.12
Net Cash from Financing Activities-8.91-5.76-0.08-1.08330.70332.261.180.12
Summary
Effect of Forex Changes on Cash-0.34-0.08-0.070.07-0.010.000.000.00
Net Change in Cash11.59-9.37-15.4041.20-7.11-4.69-10.02-11.24
Cash at Beginning of Period19.6529.0244.423.23-12.2822.2933.53
Cash at End of Period31.2319.6529.0244.42-7.5812.2822.29
Free Cash Flow-59.92-35.51-34.46-37.86-22.12-15.91-11.20-11.16
Supplemental Disclosures
Interest Paid----0.01---
Income Taxes Paid--0.02-----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Strata Critical Medical Cash Flow

What is Strata Critical Medical's free cash flow?

Strata Critical Medical had negative free cash flow of $59.92M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$48.91M minus $11.01M of capital expenditures.

How much does Strata Critical Medical spend on capital expenditures?

Strata Critical Medical spent $11.01M on capital expenditures in fiscal 2025, compared with $32.99M a year earlier.

Does Strata Critical Medical pay dividends or buy back shares?

Yes. In fiscal 2025 Strata Critical Medical returned $9.11M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition